AnnMarie Liapakis
- Hepatology top 1%
- Hepatitis C virus research 13
- Liver Disease and Transplantation 11
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments 4
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 12
- Hepatitis B Virus Studies 5
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 4
-
- Organ Transplantation Techniques and Outcomes 11
-
- Organ Donation and Transplantation 6
- Co-authors
- David R. NelsonJoseph K. LimDavid RothPaul MartinStanislas PolAnnette BruchfeldTarek HassaneinMichael Robertson
- Partner nations
- United StatesTürkiyeSpain
In The Last Decade
AnnMarie Liapakis
32 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 59
- Hepatology 906
- Transplantation 152
- Epidemiology 702
- Infectious Diseases 228
- Family Practice 10
Countries citing papers authored by AnnMarie Liapakis
This map shows the geographic impact of AnnMarie Liapakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AnnMarie Liapakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AnnMarie Liapakis more than expected).
Fields of papers citing papers by AnnMarie Liapakis
This network shows the impact of papers produced by AnnMarie Liapakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AnnMarie Liapakis. The network helps show where AnnMarie Liapakis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside AnnMarie Liapakis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 12 | |
| 3 | 2023 | 15 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 2 | |
| 11 | 2019 | 3 | |
| 12 | 2018 | 3 | |
| 13 | 2018 | 37 | |
| 14 | 2018 | 2 | |
| 15 | 2018 | 8 | |
| 16 | 2017 | 33 | |
| 17 | Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 studybreakdown → | 2015 | 477 |
| 18 | 2015 | 52 | |
| 19 | 2015 | 26 | |
| 20 | 2011 | 10 |
About AnnMarie Liapakis
AnnMarie Liapakis is a scholar working on Hepatology, Transplantation and Family Practice, having authored 33 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (11 papers), Organ Transplantation Techniques and Outcomes (11 papers), Organ Donation and Transplantation (6 papers), Hepatitis B Virus Studies (5 papers), Renal Transplantation Outcomes and Treatments (4 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Hepatology (906 citations), Transplantation (152 citations) and Epidemiology (702 citations). AnnMarie Liapakis has collaborated with scholars based in United States, Türkiye and Spain. Frequent co-authors include David R. Nelson, Joseph K. Lim, David Roth, Paul Martin, Stanislas Pol, Annette Bruchfeld, Tarek Hassanein, Michael Robertson, Howard Monsour and Wayne Greaves. Their work appears in journals such as The Lancet, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.